Cardiovascular risk assessment in haemophilia patients

 

 Buy Article Permissions and Reprints

Summary

Haemophilia patients have a reduced cardiovascular mortality, which may be the result of a lifelong deficiency of factor VIII or IX. On the other hand, the prevalence of risk factors may differ in these chronically ill patients compared to the general population. The prevalence of risk factors and expected risk of cardiovascular disease was compared in haemophilia patients and healthy controls. In adult haemophilia A and B patients, body mass index, blood pressure, cholesterol levels and fasting glucose levels were measured and compared to healthy age-matched males. The expected risk of mortality due to cardiovascular disease was calculated using a European risk prediction algorithm (SCORE). A total of 100 haemophilia A and B patients and 200 healthy controls were analysed. The mean age of the patients was 47 years (range 18–83). The number of haemophiliacs with hyperglycaemia (24%) and hypertension (51%) was higher than in the controls (p-values 0.001 and 0.03, respectively). The mean low-density lipoprotein (LDL) cholesterol level in cases was lower than the controls (3.02 mM (0.69–6.57) and 3.60 mM (1.68–5.95), respectively, p < 0.001). Fewer cases had increased LDL levels (p=0.045). No difference was found in the 10-year cardiovascular mortality risk >10% between cases and controls (12% and 7%, respectively, p = 0.18). The prevalence of risk factors and expected risk of cardiovascular disease in haemophilia patients is comparable to the general population. This strengthens the hypothesis that hypocoagulability may reduce cardiovascular mortality in haemophilia patients.

• References

• 1 Lewington S, Clarke R, Qizilbash N. et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
  CrossrefPubMedGoogle Scholar
• 2 Miura K, Daviglus ML, Dyer AR. et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases and all causes in young adult men. Arch Intern Med 2001; 161: 1501-1508.
  CrossrefPubMedGoogle Scholar
• 3 Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 2008; 118: 672-677.
  CrossrefPubMedGoogle Scholar
• 4 Ockene IS, Miller NH. For the American Heart Association Task Force on Risk Reduction. Cigarette Smoking, Cardiovascular Disease, and Stroke. Circulation 1997; 96: 3243-3247.
  CrossrefPubMedGoogle Scholar
• 5 Kannel WB, McGee Dl. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979; 59: 8-13.
  CrossrefPubMedGoogle Scholar
• 6 Krauss RM, Winston M, Fletcher BJ. et al. Obesity: impact on cardiovascular disease. Circulation 1998; 98: 1472-1476.
  CrossrefPubMedGoogle Scholar
• 7 Stec JJ, Silbershatz H, Tofler GH. et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring population. Circulation 2000; 102: 1634-1638.
  CrossrefPubMedGoogle Scholar
• 8 Frankel DS, Meigs JB, Massaro JM. et al. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the Framingham offspring study. Circulation 2008; 118: 2533-2539.
  CrossrefPubMedGoogle Scholar
• 9 Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21: 731-738.
  CrossrefPubMedGoogle Scholar
• 10 Bank I, Libourel EJ, Middeldorp S. et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost 2005; 3: 79-84.
  CrossrefPubMedGoogle Scholar
• 11 Rosendaal FR, Varekamp I, Smit C. et al. Mortality and causes of death in Dutch haemophiliacs, 1973–86. Br J Haematol 1989; 71: 71-76.
  CrossrefPubMedGoogle Scholar
• 12 Darby SC, Kan SW, Spooner RJ. et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-825.
  CrossrefPubMedGoogle Scholar
• 13 Tagliaferri A, Rivolta GF, Iorio A. et al. Mortality and causes of death in Italian persons with haemophilia, 1990–2007. Haemophilia 2010; 16: 437-446.
  PubMedGoogle Scholar
• 14 Plug I, van der Bom JG, Peters M. et al. Mortality and causes of death in patients with haemophilia, 1992–2001: a prospective cohort study. J Thromb Haemost 2006; 4: 510-516.
  CrossrefPubMedGoogle Scholar
• 15 Rosendaal FR, Briet E, Stibbe J. et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990; 75: 525-530.
  CrossrefPubMedGoogle Scholar
• 16 Conroy RM, Pyörälä K, Fitzgerald AP. et al. SCORE project group.. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
  CrossrefPubMedGoogle Scholar
• 17 Foley CJ, Nichols L, Jeong K. et al. Coronary atherosclerosis and cardiovascular mortality in Hemophilia. J Thromb Haemost 2010; 8: 208-2011.
  CrossrefPubMedGoogle Scholar
• 18 Franchini M, Favaloro EJ, Lippi G. Mild hemophilia A. J Thromb Haemost 2010; 8: 421-432.
  CrossrefPubMedGoogle Scholar
• 19 Funston R, Levine E, Stables DP. Spontaneous renal hemorrhage. Urology 1976; 8: 610-617.
  CrossrefPubMedGoogle Scholar
• 20 Coppola A, De Simone C, Di Capua M. et al. Acute coronary syndrome and severe haemophilia: An unusual association with challenging treatment. Thromb Haemost 2010; 103: 1270-1272.
  Article in Thieme ConnectPubMedGoogle Scholar